Logo image of ASGN

ASGN INC (ASGN) Stock Fundamental Analysis

NYSE:ASGN - US00191U1025 - Common Stock

53.16 USD
+2.3 (+4.52%)
Last: 9/11/2025, 4:20:02 PM
53.16 USD
0 (0%)
After Hours: 9/11/2025, 4:20:02 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ASGN. ASGN was compared to 85 industry peers in the IT Services industry. ASGN has an average financial health and profitability rating. ASGN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ASGN was profitable.
ASGN had a positive operating cash flow in the past year.
ASGN had positive earnings in each of the past 5 years.
Each year in the past 5 years ASGN had a positive operating cash flow.
ASGN Yearly Net Income VS EBIT VS OCF VS FCFASGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 3.77%, ASGN is doing good in the industry, outperforming 62.35% of the companies in the same industry.
ASGN has a better Return On Equity (7.67%) than 62.35% of its industry peers.
With a decent Return On Invested Capital value of 5.97%, ASGN is doing good in the industry, outperforming 61.18% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ASGN is significantly below the industry average of 21.77%.
Industry RankSector Rank
ROA 3.77%
ROE 7.67%
ROIC 5.97%
ROA(3y)6.26%
ROA(5y)7.32%
ROE(3y)11.85%
ROE(5y)14.03%
ROIC(3y)8.44%
ROIC(5y)8.19%
ASGN Yearly ROA, ROE, ROICASGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ASGN has a Profit Margin (3.50%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ASGN has declined.
With a Operating Margin value of 6.67%, ASGN perfoms like the industry average, outperforming 57.65% of the companies in the same industry.
In the last couple of years the Operating Margin of ASGN has declined.
Looking at the Gross Margin, with a value of 28.84%, ASGN is doing worse than 64.71% of the companies in the same industry.
ASGN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.67%
PM (TTM) 3.5%
GM 28.84%
OM growth 3Y-5.33%
OM growth 5Y-1.69%
PM growth 3Y-25.23%
PM growth 5Y-3.53%
GM growth 3Y0.44%
GM growth 5Y0.3%
ASGN Yearly Profit, Operating, Gross MarginsASGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

ASGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ASGN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ASGN has less shares outstanding
Compared to 1 year ago, ASGN has a worse debt to assets ratio.
ASGN Yearly Shares OutstandingASGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASGN Yearly Total Debt VS Total AssetsASGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

ASGN has an Altman-Z score of 2.59. This is not the best score and indicates that ASGN is in the grey zone with still only limited risk for bankruptcy at the moment.
ASGN has a Altman-Z score of 2.59. This is comparable to the rest of the industry: ASGN outperforms 47.06% of its industry peers.
ASGN has a debt to FCF ratio of 3.57. This is a good value and a sign of high solvency as ASGN would need 3.57 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.57, ASGN is in the better half of the industry, outperforming 62.35% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that ASGN is somewhat dependend on debt financing.
ASGN has a worse Debt to Equity ratio (0.66) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.57
Altman-Z 2.59
ROIC/WACC0.69
WACC8.62%
ASGN Yearly LT Debt VS Equity VS FCFASGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.11 indicates that ASGN has no problem at all paying its short term obligations.
ASGN has a Current ratio (2.11) which is in line with its industry peers.
ASGN has a Quick Ratio of 2.11. This indicates that ASGN is financially healthy and has no problem in meeting its short term obligations.
ASGN has a Quick ratio of 2.11. This is in the better half of the industry: ASGN outperforms 61.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ASGN Yearly Current Assets VS Current LiabilitesASGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for ASGN have decreased strongly by -15.04% in the last year.
ASGN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.16% yearly.
ASGN shows a decrease in Revenue. In the last year, the revenue decreased by -6.31%.
Measured over the past years, ASGN shows a small growth in Revenue. The Revenue has been growing by 3.72% on average per year.
EPS 1Y (TTM)-15.04%
EPS 3Y-2.25%
EPS 5Y2.16%
EPS Q2Q%-13.97%
Revenue 1Y (TTM)-6.31%
Revenue growth 3Y0.74%
Revenue growth 5Y3.72%
Sales Q2Q%-1.36%

3.2 Future

Based on estimates for the next years, ASGN will show a small growth in Earnings Per Share. The EPS will grow by 4.24% on average per year.
The Revenue is expected to grow by 1.63% on average over the next years.
EPS Next Y-12.54%
EPS Next 2Y-1.08%
EPS Next 3Y4.24%
EPS Next 5YN/A
Revenue Next Year-3.48%
Revenue Next 2Y-0.57%
Revenue Next 3Y1.63%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ASGN Yearly Revenue VS EstimatesASGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
ASGN Yearly EPS VS EstimatesASGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.07, the valuation of ASGN can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ASGN indicates a rather cheap valuation: ASGN is cheaper than 89.41% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, ASGN is valued rather cheaply.
ASGN is valuated reasonably with a Price/Forward Earnings ratio of 10.39.
Based on the Price/Forward Earnings ratio, ASGN is valued cheaply inside the industry as 89.41% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.54, ASGN is valued rather cheaply.
Industry RankSector Rank
PE 11.08
Fwd PE 10.39
ASGN Price Earnings VS Forward Price EarningsASGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASGN is valued cheaper than 83.53% of the companies in the same industry.
96.47% of the companies in the same industry are more expensive than ASGN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.86
EV/EBITDA 8.95
ASGN Per share dataASGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.13
EPS Next 2Y-1.08%
EPS Next 3Y4.24%

0

5. Dividend

5.1 Amount

No dividends for ASGN!.
Industry RankSector Rank
Dividend Yield N/A

ASGN INC

NYSE:ASGN (9/11/2025, 4:20:02 PM)

After market: 53.16 0 (0%)

53.16

+2.3 (+4.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners100.52%
Inst Owner Change-2.53%
Ins Owners3.59%
Ins Owner Change-0.02%
Market Cap2.33B
Analysts72.31
Price Target58.65 (10.33%)
Short Float %4.54%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.37%
Min EPS beat(2)-5.06%
Max EPS beat(2)5.79%
EPS beat(4)3
Avg EPS beat(4)1.87%
Min EPS beat(4)-5.06%
Max EPS beat(4)5.79%
EPS beat(8)7
Avg EPS beat(8)2.52%
EPS beat(12)8
Avg EPS beat(12)1.43%
EPS beat(16)12
Avg EPS beat(16)3.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)0.55%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)0.55%
Revenue beat(8)1
Avg Revenue beat(8)-1.6%
Revenue beat(12)1
Avg Revenue beat(12)-1.77%
Revenue beat(16)3
Avg Revenue beat(16)-1.28%
PT rev (1m)-3.09%
PT rev (3m)-6.25%
EPS NQ rev (1m)0.59%
EPS NQ rev (3m)-13.43%
EPS NY rev (1m)1.52%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 11.08
Fwd PE 10.39
P/S 0.58
P/FCF 6.86
P/OCF 6.16
P/B 1.27
P/tB N/A
EV/EBITDA 8.95
EPS(TTM)4.8
EY9.03%
EPS(NY)5.12
Fwd EY9.63%
FCF(TTM)7.74
FCFY14.57%
OCF(TTM)8.62
OCFY16.22%
SpS91.44
BVpS41.71
TBVpS-18.3
PEG (NY)N/A
PEG (5Y)5.13
Profitability
Industry RankSector Rank
ROA 3.77%
ROE 7.67%
ROCE 8.14%
ROIC 5.97%
ROICexc 6.23%
ROICexgc 38.16%
OM 6.67%
PM (TTM) 3.5%
GM 28.84%
FCFM 8.47%
ROA(3y)6.26%
ROA(5y)7.32%
ROE(3y)11.85%
ROE(5y)14.03%
ROIC(3y)8.44%
ROIC(5y)8.19%
ROICexc(3y)8.85%
ROICexc(5y)8.94%
ROICexgc(3y)45.83%
ROICexgc(5y)47.14%
ROCE(3y)11.51%
ROCE(5y)11.17%
ROICexcg growth 3Y-8.35%
ROICexcg growth 5Y2.66%
ROICexc growth 3Y-8.5%
ROICexc growth 5Y-0.68%
OM growth 3Y-5.33%
OM growth 5Y-1.69%
PM growth 3Y-25.23%
PM growth 5Y-3.53%
GM growth 3Y0.44%
GM growth 5Y0.3%
F-Score5
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.57
Debt/EBITDA 3.29
Cap/Depr 37.89%
Cap/Sales 0.96%
Interest Coverage 4.15
Cash Conversion 102.47%
Profit Quality 242.11%
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 2.59
F-Score5
WACC8.62%
ROIC/WACC0.69
Cap/Depr(3y)39.16%
Cap/Depr(5y)38.51%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.87%
Profit Quality(3y)166.38%
Profit Quality(5y)146.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.04%
EPS 3Y-2.25%
EPS 5Y2.16%
EPS Q2Q%-13.97%
EPS Next Y-12.54%
EPS Next 2Y-1.08%
EPS Next 3Y4.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.31%
Revenue growth 3Y0.74%
Revenue growth 5Y3.72%
Sales Q2Q%-1.36%
Revenue Next Year-3.48%
Revenue Next 2Y-0.57%
Revenue Next 3Y1.63%
Revenue Next 5YN/A
EBIT growth 1Y-19.89%
EBIT growth 3Y-4.63%
EBIT growth 5Y1.96%
EBIT Next Year37.71%
EBIT Next 3Y16.33%
EBIT Next 5YN/A
FCF growth 1Y7.89%
FCF growth 3Y31.88%
FCF growth 5Y5.39%
OCF growth 1Y5.98%
OCF growth 3Y27.34%
OCF growth 5Y5.01%